Figure 2 | International Journal of Obesity

Figure 2

From: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Figure 2

(a) Mean changes in body weight and waist circumference from randomization to years 1 and 2. (b) Participants with >5 and >10% randomization weight loss at years 1 and 2. (c) Mean changes in BP and pulse rate from randomization to years 1 and 2. Estimated mean changes in weight, waist, BP and pulse rate (by ANCOVA), and in weight-loss responders (by logistic regression) are shown for the intention-to-treat population with the last observation carried forward.

Back to article page